Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2009-06-19
2010-10-12
Carlson, Karen Cochrane (Department: 1656)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Reexamination Certificate
active
07812119
ABSTRACT:
The present invention provides an improved coating for surfaces of medical implants. The coating comprises at least one interfacial biomaterial (IFBM) which is comprised of at least one binding module that binds to the surface of an implant or implant-related material (“implant module”) and at least one binding module that selectively binds to a target analyte or that is designed to have a desired effect (“analyte module”). The modules are connected by a linker. In some embodiments, the IFBM coating acts to promote the recognition and attachment of target analytes to surface of the device. The IFBM coating improves the performance of implanted medical devices, for example, by promoting osteointegration of the implant.
REFERENCES:
patent: 4394320 (1983-07-01), Pereyre et al.
patent: 4472840 (1984-09-01), Jefferies
patent: 4526909 (1985-07-01), Urist
patent: 4563489 (1986-01-01), Urist
patent: 5013649 (1991-05-01), Wang et al.
patent: 5236456 (1993-08-01), O'Leary et al.
patent: 5264563 (1993-11-01), Huse
patent: 5344654 (1994-09-01), Rueger et al.
patent: 5597897 (1997-01-01), Ron et al.
patent: 5606019 (1997-02-01), Cappello
patent: 5629009 (1997-05-01), Laurencin et al.
patent: 5635373 (1997-06-01), Wozney et al.
patent: 5645591 (1997-07-01), Kuberasampath et al.
patent: 5652118 (1997-07-01), Ozkaynak et al.
patent: 5683459 (1997-11-01), Brekke
patent: 5714589 (1998-02-01), Oppermann et al.
patent: 5756332 (1998-05-01), Hillman
patent: 5766925 (1998-06-01), Sugimoto et al.
patent: 5824483 (1998-10-01), Houston, Jr. et al.
patent: 6544768 (2003-04-01), Buck et al.
patent: 6605592 (2003-08-01), Ni et al.
patent: 6632920 (2003-10-01), Olsen et al.
patent: 6716811 (2004-04-01), Cwirla et al.
patent: 6962799 (2005-11-01), Yue et al.
patent: 7132506 (2006-11-01), Nishimura et al.
patent: 7166574 (2007-01-01), Pena et al.
patent: 7176275 (2007-02-01), Bogoch et al.
patent: 7314974 (2008-01-01), Cao et al.
patent: 7355022 (2008-04-01), Kere et al.
patent: 7491691 (2009-02-01), Sindrey et al.
patent: 7528105 (2009-05-01), Pena et al.
patent: 7635752 (2009-12-01), Cattaneo et al.
patent: 2004/0123343 (2004-06-01), La Rosa et al.
patent: 2004/0176287 (2004-09-01), Harrison et al.
patent: 2006/0127894 (2006-06-01), Azimzai et al.
patent: 2007/0160681 (2007-07-01), Park et al.
patent: 2008/0241108 (2008-10-01), Murray et al.
Lebaron and Athanasiou (2000) Extracellular Matrix Cell Adhesion Peptides: Functional Applications in Orthopedic Materials, Tissue Eng. 6: 85-103.
Yamada (1997) Integrin Signaling, Matrix Biol. 16: 137-141.
Kantlehner et al (2000). Surface Coating with Cyclic RGD Peptides Stimulates Osteoblast Adhesion and Proliferation as well as Bone Formation, ChemBioChem 1: 107-114.
Sarmento et al. (2004) In Vitro Behavior of Osteoblastic Cells Cultured in the Presence of Pseudowollastonite Ceramic, J. Biomed. Mater. Res. 69A: 351-358.
Hayashibara et al. (2004) A Synthetic Peptide Fragment of Human MEPE Stimulates New Bone Formation in vitro and in vivo, J. Bone Mineral Res. 19: 455-462.
Cole et al. (1997) Use of Bone Morphogenetic Protein 2 on Ectopic Porous Coated Implants in the Rat, Clin. Orthop. 345: 219-228.
Friedlander et al. (2001) Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions, J. Bone Joint Surg. Am. 83-A Suppl. 1 (Pt. 2): S151-58.
Einhorn (2003) Clinical Applications of Recombinant Human BMPs: Early Experience and Future Development, J. Bone Joint Surg. Am. 85-A Supp1.3: 82-88.
Burkus et al. (2002) Anterior Lumbar Interbody Fusion Using rhBMP-2 With Tapered Interbody Cages, J. Spinal Disord. Tech. 15(5): 337-49.
Geiger et al. (2003) Collagen Sponges for Bone Regeneration with rhBMP-2, Adv. Drug Del. Rev. 55: 1613-1629.
Hersel et al. (2003) RGD Modified Polymers: Biomaterials for Stimulated Cell Adhesion and Beyond, Biomaterials 24: 4385-4415.
Grant et al. (1990) The Role of Basement Membranes in Vascular Development, Ann. N.Y. Acad. Sci. 588: 61-72.
Hosokawa et al. (1999) Significant Role of Laminin-1 in Branching Morphogenesis of Mouse Salivary Epithelium Cultured in Basement Membrane Matrix, Dev. Growth Differ. 41: 207-216.
Wang et al. (2005) Thrombin Peptide (TP508) Promotes Fracture Repair Bby Up-regulating Inflammatory Mediators, Early Growth Factors, and Increasing Angiogenesis, J Orthop Res. 23(3):671-9.
Yang et al. (2004) Biomimetic Collagen Scaffolds for Human Bone Cell Growth and Differentiation, Tissue Eng. 10 (7-8): 1148-59.
Scarano et al. (2003) Cortical Bone Regeneration With a Synthetic Cell-Binding Peptide: A Histologic and Histomorphometric Pilot Study, Implant Dent. 12(4): 318-24.
Saito et al. (2005) Accelerated Bone Repair with the Use of a Synthetic BMP-2-Derived Peptide and Bone-marrow Stromal Cells, J Biomed Mater Res A 72A(1): 77-82.
Benson Ray Edward
Beyer, Jr. Wayne F.
Hamilton Paul T.
Hyde-DeRuyscher Robin
Affinergy, Inc.
Carlson Karen Cochrane
Kiefer Laura L.
LandOfFree
IFBM's to promote the specific attachment of target analytes... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IFBM's to promote the specific attachment of target analytes..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IFBM's to promote the specific attachment of target analytes... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4234462